STOCK TITAN
  1. Home
  2. CEREW

CEREVEL THERAPEU Stock Price, News & Analysis

CEREW NASDAQ

Company Description

CEREVEL THERAPEU (NASDAQ: CEREW) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

CEREW stock has gained 998.5% over the past year.

This page provides a comprehensive overview of CEREW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+998.48%
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

CEREVEL THERAPEU (CEREW) stock. Over the past 12 months, the stock has gained 998.5%.

Latest News

View All
—

Cerevel Therapeutics to Present at the Jefferies Healthcare Conference

conferences
—

Cerevel Therapeutics Reports First Quarter 2022 Financial Results and Business Updates

earnings
—

Cerevel Therapeutics to Report First Quarter 2022 Financial Results and Pipeline Update on Tuesday, May 10, 2022

conferences earnings
—

Cerevel Therapeutics Announces Upcoming Presentations at AAN 2022

conferences
—

Cerevel Therapeutics to Present at the Stifel 4th Annual CNS Day Event

conferences
—

Cerevel Therapeutics Provides Update on Pipeline Progress along with Fourth Quarter and Full Year 2021 Financial Results

earnings

CEREVEL THERAPEU has 10 recent news articles. Key topics include conferences, earnings, clinical trial. View all CEREW news →

SEC Filings

View All

No SEC filings available for CEREW.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CEREW Company Profile & Sector Positioning

CEREVEL THERAPEU (CEREW) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.